pancreatic cancer
Showing NaN - NaN of 143
Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States
Recruiting
- Invasive Ductal Breast Carcinoma
- +14 more
- Stereotactic body radiotherapy
- Lattice Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Apr 20, 2023
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With
Recruiting
- Pancreatic Cancer
- +4 more
- PET Scan
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 10, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Pancreatic Cancer Trial in New York (Chemotherapy, Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA))
Not yet recruiting
- Pancreatic Cancer
- Chemotherapy
- Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
-
New York, New YorkTisch Hospital
Feb 9, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)
Completed
- Pancreatic Cancer
- +2 more
- AMG820 and pembrolizumab
-
Atlanta, Georgia
- +14 more
Jan 18, 2023
Pancreatic Cancer, Pancreas Cancer, Pancreatic Diseases Trial in Canada, United States (Cefoxitin, Piperacillin-tazobactam)
Active, not recruiting
- Pancreatic Cancer
- +2 more
-
Sacramento, California
- +31 more
Jan 12, 2023
Predict and Treat High Glucose Levels After Steroid Treatment
Recruiting
- Breast Cancer
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 12, 2022
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in New York (PET Scan)
Recruiting
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- PET Scan
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 16, 2022
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Pancreatic Cancer Trial in United States (MVT-5873, modified FOLFIRINOX (mFOLFIRINOX))
Recruiting
- Pancreatic Cancer
- MVT-5873
- modified FOLFIRINOX (mFOLFIRINOX)
-
Scottsdale, Arizona
- +3 more
Aug 17, 2022
Intestinal Microbiome, Oral Microbiome, and Whole Blood
Recruiting
- Gastrointestinal Cancer
- +6 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 5, 2022
Pancreatic Cancer Trial in Basking Ridge, Commack, New York (Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent,
Active, not recruiting
- Pancreatic Cancer
- Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml
- +2 more
-
Basking Ridge, New Jersey
- +2 more
Aug 8, 2022
Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in United States (drug,
Recruiting
- Pancreatic Adenosquamous Carcinoma
- +2 more
- Oxaliplatin
- +5 more
-
Mobile, Alabama
- +182 more
Aug 1, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
-
Grand Rapids, Michigan
- +2 more
Jul 18, 2022